{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:52:59Z","timestamp":1770220379660,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,25]],"date-time":"2015-07-25T00:00:00Z","timestamp":1437782400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12917-015-0475-9","type":"journal-article","created":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T00:20:53Z","timestamp":1437697253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs"],"prefix":"10.1186","volume":"11","author":[{"given":"Bettina","family":"Wagner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Garcia-Tapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Honsberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vickie","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Strietzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Hardham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick F. M.","family":"Meeus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,25]]},"reference":[{"issue":"2","key":"475_CR1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1939-1676.2006.tb02880.x","volume":"20","author":"MP Littman","year":"2006","unstructured":"Littman MP, Goldstein RE, Labato MA, Lappin MR, Moore GE. ACVIM small animal consensus statement on Lyme disease in dogs: diagnosis, treatment, and prevention. J Vet Intern Med. 2006;20(2):422\u201334.","journal-title":"J Vet Intern Med"},{"issue":"6","key":"475_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.cvsm.2010.07.011","volume":"40","author":"I Krupka","year":"2010","unstructured":"Krupka I, Straubinger RK. Lyme borreliosis in dogs and cats: background, diagnosis, treatment and prevention of infections with Borrelia burgdorferi sensu stricto. Vet Clin North Am Small Anim Pract. 2010;40(6):1103\u201319.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"4","key":"475_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pt.2010.01.006","volume":"26","author":"SE Little","year":"2010","unstructured":"Little SE, Heise SR, Blagburn BL, Callister SM, Mead PS. Lyme borreliosis in dogs and humans in the USA. Trends Parasitol. 2010;26(4):213\u20138.","journal-title":"Trends Parasitol"},{"issue":"2\u20134","key":"475_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.prevetmed.2011.01.006","volume":"99","author":"I Van Vlaenderen","year":"2011","unstructured":"Van Vlaenderen I, Nautrup BP, Gasper SM. Estimation of the clinical and economic consequences of non-compliance with antimicrobial treatment of canine skin infections. Prev Vet Med. 2011;99(2\u20134):201\u201310.","journal-title":"Prev Vet Med"},{"issue":"6","key":"475_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2885.2006.00801.x","volume":"29","author":"MR Stegemann","year":"2006","unstructured":"Stegemann MR, Sherington J, Blanchflower S. Pharmacokinetics and pharmacodynamics of cefovecin in dogs. J Vet Pharmacol Ther. 2006;29(6):501\u201311.","journal-title":"J Vet Pharmacol Ther"},{"issue":"7","key":"475_CR6","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1128\/AAC.00077-06","volume":"50","author":"MR Stegemann","year":"2006","unstructured":"Stegemann MR, Passmore CA, Sherington J, Lindeman CJ, Papp G, Weigel DJ, et al. Antimicrobial activity and spectrum of cefovecin, a new extended- spectrum cephalosporin, against pathogens collected from dogs and cats in Europe and North America. Antimicrob Agents Chemother. 2006;50(7):2286\u201392.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"475_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/infdis\/167.3.651","volume":"167","author":"MJ Appel","year":"1993","unstructured":"Appel MJ, Allan S, Jacobson RH, Lauderdale TL, Chang YF, Shin SJ, et al. Experimental Lyme disease in dogs produces arthritis and persistent infection. J Infect Dis. 1993;167(3):651\u201364.","journal-title":"J Infect Dis"},{"issue":"1","key":"475_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcpa.2004.11.006","volume":"133","author":"BA Summers","year":"2005","unstructured":"Summers BA, Straubinger AF, Jacobson RH, Chang YF, Appel MJ, Straubinger RK. Histopathological studies of experimental lyme disease in the dog. J Comp Pathol. 2005;133(1):1\u201313.","journal-title":"J Comp Pathol"},{"issue":"7","key":"475_CR9","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.2460\/ajvr.2001.62.1104","volume":"62","author":"YF Chang","year":"2001","unstructured":"Chang YF, Novosel V, Chang CF, Summers BA, Ma DP, Chiang YW, et al. Experimental induction of chronic borreliosis in adult dogs exposed to Borrelia burgdorferi-infected ticks and treated with dexamethasone. Am J Vet Res. 2001;62(7):1104\u201312.","journal-title":"Am J Vet Res"},{"issue":"24","key":"475_CR10","first-page":"874","volume":"110","author":"RK Straubinger","year":"1998","unstructured":"Straubinger RK, Straubinger AF, Summers BA, Jacobson RH, Erb HN. Clinical manifestations, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogs. Wien Klin Wochenschr. 1998;110(24):874\u201381.","journal-title":"Wien Klin Wochenschr"},{"issue":"3","key":"475_CR11","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1086\/315340","volume":"181","author":"RK Straubinger","year":"2000","unstructured":"Straubinger RK, Straubinger AF, Summers BA, Jacobson RH. Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: An experimental study. J Infect Dis. 2000;181(3):1069\u201381.","journal-title":"J Infect Dis"},{"issue":"3","key":"475_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/0300985811424754","volume":"49","author":"L Susta","year":"2012","unstructured":"Susta L, Uhl EW, Grosenbaugh DA, Krimer PM. Synovial lesions in experimental canine Lyme borreliosis. Vet Pathol. 2012;49(3):453\u201361.","journal-title":"Vet Pathol"},{"issue":"4","key":"475_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1128\/CVI.05653-11","volume":"19","author":"B Wagner","year":"2012","unstructured":"Wagner B, Freer H, Rollins A, Garcia-Tapia D, Erb HN, Earnhart C, et al. Antibodies to Borrelia burgdorferi OspA, OspC, OspF, and C6 antigens as markers for early and late infection in dogs. Clin Vaccine Immunol. 2012;19(4):527\u201335.","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"475_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1128\/CVI.00340-07","volume":"15","author":"SA Levy","year":"2008","unstructured":"Levy SA, O\u2019Connor TP, Hanscom JL, Shields P, Lorentzen L, Dimarco AA. Quantitative measurement of C6 antibody following antibiotic treatment of Borrelia burgdorferi antibody-positive nonclinical dogs. Clin Vaccine Immunol. 2008;15(1):115\u20139.","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"475_CR15","first-page":"308","volume":"3","author":"S Levy","year":"2002","unstructured":"Levy S, O\u2019Connor TP, Hanscom JL, Shields P. Utility of an in-office C6 ELISA test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi. Vet Ther. 2002;3(3):308\u201315.","journal-title":"Vet Ther"},{"issue":"2","key":"475_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/vec.12026","volume":"23","author":"MP Littman","year":"2013","unstructured":"Littman MP. Lyme nephritis. J Vet Emerg Crit Care (San Antonio). 2013;23(2):163\u201373.","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"475_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1746-6148-5-18","volume":"5","author":"B Gerber","year":"2009","unstructured":"Gerber B, Haug K, Eichenberger S, Reusch CE, Wittenbrink MM. Follow-up of Bernese Mountain dogs and other dogs with serologically diagnosed Borrelia burgdorferi infection: what happens to seropositive animals? BMC Vet Res. 2009;5:18.","journal-title":"BMC Vet Res"},{"issue":"3","key":"475_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tvjl.2008.08.022","volume":"182","author":"B Gerber","year":"2009","unstructured":"Gerber B, Eichenberger S, Haug K, Wittenbrink MM, Reusch CE. Association of urine protein excretion and infection with Borrelia burgdorferi sensu lato in Bernese Mountain dogs. Vet J. 2009;182(3):487\u20138.","journal-title":"Vet J"},{"issue":"4","key":"475_CR19","first-page":"392","volume":"54","author":"BS Horney","year":"2013","unstructured":"Horney BS, Stojanovic V. Protein-losing nephropathy associated with Borrelia burgdorferi seropositivity in a soft-coated wheaten terrier: response to therapy. Can Vet J. 2013;54(4):392\u20136.","journal-title":"Can Vet J"},{"issue":"Suppl 1","key":"475_CR20","first-page":"S60","volume":"27","author":"RE Goldstein","year":"2013","unstructured":"Goldstein RE, Brovida C, Fernandez-Del Palacio MJ, Littman MP, Polzin DJ, Zatelli A, et al. Consensus recommendations for treatment for dogs with serology positive glomerular disease. J Vet Intern Med. 2013;27 Suppl 1:S60\u20136.","journal-title":"J Vet Intern Med"},{"issue":"1","key":"475_CR21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/jcm.35.1.111-116.1997","volume":"35","author":"RK Straubinger","year":"1997","unstructured":"Straubinger RK, Summers BA, Chang YF, Appel MJ. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol. 1997;35(1):111\u20136.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"475_CR22","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1128\/jcm.30.10.2692-2697.1992","volume":"30","author":"LL Dever","year":"1992","unstructured":"Dever LL, Jorgensen JH, Barbour AG. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol. 1992;30(10):2692\u20137.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"475_CR23","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1128\/AAC.37.7.1444","volume":"37","author":"JM Levin","year":"1993","unstructured":"Levin JM, Nelson JA, Segreti J, Harrison B, Benson CA, Strle F. In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents. Antimicrob Agents Chemother. 1993;37(7):1444\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"475_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ijantimicag.2005.02.007","volume":"25","author":"E Ruzic-Sabljic","year":"2005","unstructured":"Ruzic-Sabljic E, Podreka T, Maraspin V, Strle F. Susceptibility of Borrelia afzelii strains to antimicrobial agents. Int J Antimicrob Agents. 2005;25(6):474\u20138.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"475_CR25","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1128\/JCM.41.4.1791-1793.2003","volume":"41","author":"M Sicklinger","year":"2003","unstructured":"Sicklinger M, Wienecke R, Neubert U. In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto. J Clin Microbiol. 2003;41(4):1791\u20133.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"475_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1042\/AN20130010","volume":"5","author":"CA Brissette","year":"2013","unstructured":"Brissette CA, Kees ED, Burke MM, Gaultney RA, Floden AM, Watt JA. The multifaceted responses of primary human astrocytes and brain microvascular endothelial cells to the Lyme disease spirochete, Borrelia burgdorferi. ASN Neuro. 2013;5(3):221\u20139.","journal-title":"ASN Neuro"},{"issue":"8","key":"475_CR27","first-page":"311","volume":"79","author":"MC Nicholson","year":"1996","unstructured":"Nicholson MC, Mather TN, Donnelly EF. Lyme disease in Rhode Island: three years of surveillance. Med Health Rhode Island. 1996;79(8):311\u20133.","journal-title":"Med Health Rhode Island"},{"issue":"2","key":"475_CR28","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.tvjl.2013.07.019","volume":"198","author":"DV Rhodes","year":"2013","unstructured":"Rhodes DV, Earnhart CG, Mather TN, Meeus PF, Marconi RT. Identification of Borrelia burgdorferi ospC genotypes in canine tissue following tick infestation: implications for Lyme disease vaccine and diagnostic assay design. Vet J. 2013;198(2):412\u20138.","journal-title":"Vet J"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-015-0475-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-015-0475-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-015-0475-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-015-0475-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:23:59Z","timestamp":1630607039000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-015-0475-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,25]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1186\/s12917-015-0475-9","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,25]]},"assertion":[{"value":"30 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"163"}}